Oncology & Cancer

SOG: Intraperitoneal chemo ups ovarian cancer survival

(HealthDay)—Intraperitoneal (IP) chemotherapy is associated with improved survival in advanced ovarian cancer compared with standard intravenous (IV) therapy, according to a study presented at the Society of Gynecologic ...

Oncology & Cancer

Nanotech'ed RNA drug reduces ovarian cancer tumors by 83 percent

By loading fragile RNA into silicon nanoparticles, researchers from The Methodist Hospital and two other institutions found a new drug delivery system can reduce the size of ovarian tumors by as much as 83 percent—and stop ...

Oncology & Cancer

Two-step immunotherapy attacks advanced ovarian cancer

Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine ...

Oncology & Cancer

Genes behind aggressive endometrial cancer found

In a major breakthrough for uterine serous carcinoma (USC)—a chemo-resistant, aggressive form of endometrial cancer, Yale researchers have defined the genetic landscape of USC tumors, findings that point to new treatment ...

page 9 from 13